Recombinant guinea pig tumor necrosis factor alpha stimulates the expression of interleukin-12 and the inhibition of Mycobacterium tuberculosis growth in macrophages

Infection and Immunity

Volumn 73, Issue 3, 2005, Pages 1367-1376

  Cho, Hyosun ^a   Lasco, Todd M ^a,c   Allen, Shannon Sedberry ^a   Yoshimura, Teizo ^b   McMurray, David N ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GUINEA PIG TUMOR NECROSIS FACTOR ALPHA ANTIBODY; INTERLEUKIN 12; INTERLEUKIN 12P40; MESSENGER RNA; POLYCLONAL ANTIBODY; RECOMBINANT GUINEA PIG TUMOR NECROSIS FACTOR ALPHA; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG; URACIL; PROTEIN SUBUNIT; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBACTERIAL ACTIVITY; ANTIBODY TITER; ARTICLE; BACTERIAL GROWTH; BACTERIAL IMMUNITY; CELL ISOLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; DRUG ACTIVITY; DRUG ISOLATION; GROWTH INHIBITION; GUINEA PIG; HOST RESISTANCE; IMMUNE RESPONSE; IMMUNIZATION; LUNG ALVEOLUS MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RABBIT; REAL TIME POLYMERASE CHAIN REACTION; TH1 CELL; UPREGULATION; ANIMAL; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; MACROPHAGE ACTIVATION; METABOLISM; MICROBIOLOGY; PATHOGENICITY; TUBERCULOSIS;

ANIMALS; GUINEA PIGS; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P40; MACROPHAGE ACTIVATION; MACROPHAGES, ALVEOLAR; MACROPHAGES, PERITONEAL; MYCOBACTERIUM TUBERCULOSIS; PROTEIN SUBUNITS; RABBITS; RECOMBINANT PROTEINS; RNA, MESSENGER; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 15544362396     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.3.1367-1376.2005     Document Type: Article

References (53)

1. Baldwin, S. L., C. D'Souza, A. D. Roberts, B. P. Kelly, A. A. Frank, M. A., Lui, J. B. Ulmer, K. Huygen, D. M. McMurray, and I. M. Orme. 1998. Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis. Infect. Immun. 66:2951-2959.
2. Barrera, L. F., E. Skamene, and D. Radzioch. 1993. Assessment of mycobacterial infection and multiplication in macrophages by polymerase chain reaction. J. Immunol. Methods 157:91-99.
3. Bekker, L. G., A. L. Moreira, A. Bergtold, S. Freeman, B. Ryffel, and G. Kaplan. 2000. Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent. Infect. Immun. 68:6954-6961.
4. Bekker, L. G., G. Maartens, L. Steyn, and, G., Kaplan. 1998. Selective increase in plasma tumor necrosis factor-alpha and concomitant clinical deterioration after initiating therapy in patients with severe tuberculosis. J. Infect. Dis. 178:580-584.
5. Boehm, U., T. Klamp, M. Groot, and J. C. Howard. 1997. Cellular responses to interferon-gamma. Annu. Rev. Immunol. 15:749-795.
6. Botha, T., and B. Ryffel. 2003. Reactivation of latent tuberculosis infection in TNF-deficient mice. J. Immunol. 171:3110-3118.
7. Cooper, A. M., J. Magram, J. Ferrante, and I. M. Orme. 1997. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med. 186:39-45.
8. Crippen, T. L., D. W. Riches, and D. M. Hyde. 1998. Differential regulation of the expression of cytokine-induced neutrophil chemoattractant by mouse macrophages. Pathobiology 66:24-32.
9. Czermak, B. J., V. Sarma, N. M. Bless, H. Schmal, H. P. Friedl, and P. A. Ward. 1999. In vitro and in vivo dependency of chemokine generation on C5a and TNF-alpha. J. Immunol. 162:2321-2325.
10. Dempsey, P. W., S. E. Doyle, J. Q. He, and G. Cheng. 2003. The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev. 14:193-209.
11. Denis, M. 1991. Involvement of cytokines in determining resistance and acquired immunity in murine tuberculosis. J. Leukoc. Biol. 50:495-501.
12. Ding, A., C. F. Nathan, J. Graycar, R. Derynck, D. J. Stuehr, and S. Srimal. 1990. Macrophage deactivating factor and transforming growth factors-beta 1, -beta 2 and -beta 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma. J. Immunol. 145:940-944.
13. Dorger, M., S. Munzing, A. M. Allmeling, K. Messmer, and F. Krombach. 2001. Phenotypic and functional differences between rat alveolar, pleural, and peritoneal macrophages. Exp. Lung Res. 27:65-76.
14. Engele, M., E. Stoßel, K. Castiglione, N. Schwerdtner, M. Wagner, P. Bolcskei, M. Rollinghoff, and S. Stenger. 2002. Induction of TNF in human alveolar macrophages as a potential evasion mechanism of virulent Mycobacterium tuberculosis. J. Immunol. 168:1328-1337.
15. Facon, T., J. P. Jouet, M. P. Noel-Walter, F. Bloget, F. Bauters, and A. Janin. 1997. Involvement of TNF-α secreting macrophages in lethal forms of human graft-versus-host disease. Bone Marrow Transplant. 20:511-515.
16. Fenton, M. J., M. W. Vermeulen, S. Kim, M. Burdick, R. M. Stricter, and H. Kornfeld. 1997. Induction of gamma Interferon production in human alveolar macrophages by Mycobacterium tuberculosis. Infect. Immun. 65:5149-5156.
17. Flesch, I. E., J. H. Hess, S. Huang, M. Aguet, J. Rothe, H. Bluethmann, and S. H. Kaufmann. 1995. Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon gamma and tumor necrosis factor alpha. J. Exp. Med. 181:1615-1621.
18. Flesch, I. E., and S. H. Kaufmann. 1990. Activation of tuberculostatic macrophage functions by gamma interferon, interleukin-4, and tumor necrosis factor. Infect. Immun. 58:2675-2677.
19. Flynn, J. L., M. M. Goldstein, J. Chan, K. J. Triebold, K. Pfeffer, C. J. Lowenstein, R. Schreiber, T. W. Mak, and B. R. Bloom. 1995. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2:561-572.
20. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249-2254.
21. Glicman, M. S., and W. R. Jacobs, Jr. 2001. Microbial pathogenesis of Mycobacterium tuberculosis: dawn of a discipline. Cell 104:477-485.
22. Greinert, U., M. Ernst, M. Schlaak, and P. Entzian. 2001. Interleukin-12 as successful adjuvant in tuberculosis treatment. Eur. Respir. J. 17:1049-1051.
23. Grover, A. A., H. K. Kim, E. H. Wiegeshaus, and D. W. Smith. 1967. Host-parasite relationships in experimental airborne tuberculosis. II. Reproducible infection by means of an inoculum preserved at -70°C. J. Bacteriol. 94:832-835.
24. Hodge-Dufour, J., M. W. Marino, M. R. Horton, A. Jungbluth, M. D. Burdick, R. M. Stricter, P. W. Noble, C. A. Hunter, and E. Pure. 1998. Inhibition of interferon-γ induced interleukin 12 production: a potential mechanism for the anti-inflammatory activities of tumor necrosis factor. Proc. Natl. Acad. Sci. USA 95:13806-13811.
25. Hsu, T., S. M. Hingley-Wilson, B. Chen, M. Chen, A. Z. Dai, P. M. Morin, C. B. Marks, J. Padiyar, C. Goulding, M. Gingery, D. Eisenberg, R. G. Russell, S. C. Derrick, F. M. Collins, S. L. Morris, C. H. King, and W. R. Jacobs, Jr. 2003. The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue. Proc. Natl. Acad. Sci. USA 100:12420-12425.
26. Jeevan, A., T. Yoshimura, K. E. Lee, and D. N. McMurray. 2003. Differential expression of gamma interferon mRNA induced by attenuated and virulent Mycobacterium tuberculosis in guinea pig cells after Mycobacterium bovis BCG vaccination. Infect. Immun. 71:354-364.
27. Kasahara, T., N. Mukaida, K. Yamashita, H. Yagisawa, T. Akahoshi, and K. Matsushima. 1991. IL-1 and TNF-alpha induction of IL-8 and monocyte chemotactic and activating factor (MCAF) mRNA expression in a human astrocytoma cell line. Immunology 74:60-67.
28. Kaufmann, A., D. Gemsa, and H. Sprenger. 2000. Differential desensitization of lipopolysaccharide-inducible chemokine gene expression in human monocytes and macrophages. Eur. J. Immunol. 30:1562-1567.
29. Kaufmann, S. H. 2001. How can immunology contribute to the control of tuberculosis? Nat. Rev. Immunol. 1:20-30.
30. Kavanaugh, A. F. 1998. Anti-tumor necrosis factor-α monoclonal antibody therapy for rheumatoid arthritis. Rheum. Dis. Clin. N. Am. 24:593-614.
31. Kindler, V., A. P. Sappino, G. E. Grau, P. F. Piguet, and P. Vassalli. 1989. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56:731-740.
32. Kotb, M., and T. Calandra. 2003. Cytokine and chemokines, p. 151-161. In M. Koth and T. Calandra (ed.), Infectious diseases handbook. Academic Press, New York, N. Y.
33. Kubin, M., J. M. Chow, and G. Trinchieri. 1994. Differential regulation of interleukin-12 (IL-12), tumour necrosis factor-α, and IL-1β production in human myeloid cell lines and peripheral blood mononuclear cells. Blood 83:1847-1855.
34. Lane, B. R., D. M. Markovitz, N. L. Woodford, R. Rochford, R. M. Stricter, and M. J. Coffey. 1999. TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression. J. Immunol. 163:3653-3661.
35. Lasco, T. M. 2002. The role of tumor necrosis factor-alpha (TNF-α) in host resistance to experimental pulmonary tuberculosis. Ph.D. thesis. Texas A&M University, College Station.
36. Lasco, T. M., T. Yamamoto, T. Yoshimura, S. S. Allen, L. Cassone, and D. N. McMurray. 2003. Effect of Mycobacterium bovis BCG vaccination on mycobacterium-specific cellular proliferation and tumor necrosis factor alpha production from distinct guinea pig leukocyte populations. Infect. Immun. 71:7035-7042.
37. Liu, W., and R. J. Kurlander. 1995. Analysis of the interrelationship between IL-12, TNF-α and IFN-γ production during murine listeriosis. Cell. Immunol. 163:260-267.
38. Lyons, M. J., T. Yoshimura, and D. N. McMurray. 2002. Mycobacterium bovis BCG vaccination augments interleukin-8 mRNA expression and protein production in guinea pig alveolar macrophages infected with Mycobacterium tuberculosis. Infect. Immun. 70:5471-5478.
39. Ma, X., J. Sun, E. Papasavvas, H. Riemann, S. Robertson, J. Marshall, R. T. Bailer, A. Moore, R. P. Donnelly, G. Trinchieri, and L. J. Montaner. 2000. Inhibition of IL-12 production in human monocyte-derived macrophages by TNF. J. Immunol. 164:1722-1729.
40. Mainali, E. S., and D. N. McMurray. 1998. Protein deficiency induces alterations in the distribution of T-cell subsets in experimental pulmonary tuberculosis. Infect. Immun. 66:927-931.
41. Marino, M. W., A. Dunn, D. Grail, M. Inglese, Y. Noguchi, E. Richards, A. Jungbluth, H. Wada, M. Moore, B. Williamson, S. Basu, and L. J. Old. 1997. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA 94:8093-8098.
42. McMurray, D. N. 2001. Disease model: pulmonary tuberculosis. Trends MoI. Med. 7:135-137.
43. Medvedev, A. E., K. M. Kopydlowski, and S. N. Vogel. 2000. Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and toll-like receptor 2 and 4 gene expression. J. Immunol. 164:5564-5574.
44. Nolt, D., and J. L. Flynn. 2004. Interleukin-12 therapy reduces the number of immune cells and pathology in lungs of mice infected with Mycobacterium tuberculosis. Infect. Immun. 72:2976-2988.
45. Orme, I. M., A. D. Roberts, J. P. Griffin, and J. S. Abrams. 1993. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. I. Immunol. 151:518-525.
46. Reimund, J. M., C. Wittersheim, S. Dumont, C. D. Muller, R. Baumann, P. Poindron, and B. Duclos. 1996. Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease. J. Clin. Immunol. 16:144-150.
47. Roach, D. R., H. Briscoe, K. Baumgart, D. A. Rathjen, and W. J. Britton. 1999. Tumor necrosis factor (TNF) and a TNF-mimetic peptide modulate the granulomatous response to Mycobacterium bovis BCG infection in vivo. Infect. Immun. 67:5473-5476.
48. Salez, L., M. Singer, V. Balloy, C. Creminon, and M. Chignard. 2000. Lack of IL-10 synthesis by murine alveolar macrophages upon lipopolysaccharide exposure. Comparison with peritoneal macrophages. J. Leukoc. Biol. 67:545-552.
49. Scanga, C. A., V. P. Mohan, H. Joseph, K. Yu, J. Chan, and J. L. Flynn. 1999. Reactivation of latent tuberculosis: variations on the Cornell murine model. Infect. Immun. 67:4531-4538.
50. Silver, R. F., Q. Li, and J. J. Ellner. 1998. Expression of virulence of Mycobacterium tuberculosis within human monocytes: virulence correlates with intracellular growth and induction of tumor necrosis factor alpha but not with evasion of lymphocyte-dependent monocyte effector functions. Infect. Immun. 66:1190-1199.
51. Vanham, G., Z. Toossi, C. S. Hirsch, R. S. Wallis, S. K. Schwander, E. A. Rich, and J. J. Ellner. 1997. Examining a paradox in the pathogenesis of human pulmonary tuberculosis: immune activation and suppression/anergy. Tuber. Lung Dis. 78:145-158.
52. White, A.-M., T. Yoshimura, A. W. Smith, J. Westwick, and M. L. Watson. 1997. Inflammation induced by recombinant guinea-pig tumor necrosis factor-alpha. Am. J. Physiol. (Lung Cell. Mol. Physiol.) 17:L524-L530.
53. Zhan, Y., and C. Cheers. 1998. Control of 1L-12 and IFN-gamma production in response to live or dead bacteria by TNF and other factors. J. Immunol. 161:1447-1453.